Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.64
7.61
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Shandong Weigao Group Medical Polymer Co Ltd
Shandong Weigao Group Medical Polymer Co Ltd
Long-Term Investments
Shandong Weigao Group Medical Polymer Co Ltd
Long-Term Investments Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Long-Term Investments
¥2.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
|
Long-Term Investments
¥154.4m
|
CAGR 3-Years
56%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Long-Term Investments
¥128m
|
CAGR 3-Years
216%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Long-Term Investments
¥98.6m
|
CAGR 3-Years
96%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Long-Term Investments
¥1.2B
|
CAGR 3-Years
108%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Long-Term Investments
¥1.5B
|
CAGR 3-Years
57%
|
CAGR 5-Years
227%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
Glance View
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of medical devices. The company is headquartered in Weihai, Shandong. The company went IPO on 2004-02-27. The firm sells products under brand names of Jierui and Wego Ortho. The firm operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The firm is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.
See Also
What is Shandong Weigao Group Medical Polymer Co Ltd's Long-Term Investments?
Long-Term Investments
2.1B
CNY
Based on the financial report for Jun 30, 2024, Shandong Weigao Group Medical Polymer Co Ltd's Long-Term Investments amounts to 2.1B CNY.
What is Shandong Weigao Group Medical Polymer Co Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 5Y
6%
Over the last year, the Long-Term Investments growth was 0%. The average annual Long-Term Investments growth rates for Shandong Weigao Group Medical Polymer Co Ltd have been 10% over the past three years , 6% over the past five years .
You don't have any saved screeners yet
